HK Stock MarketDetailed Quotes

01652 FUSEN PHARM

Watchlist
  • 1.200
  • 0.0000.00%
Not Open May 27 16:08 CST
899.95MMarket Cap-22641P/E (TTM)

FUSEN PHARM Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
15.02%565.61M
103.15%336.44M
27.51%491.76M
-22.69%165.61M
-20.78%385.66M
-13.45%214.21M
19.51%486.85M
26.00%247.5M
-11.83%407.39M
-27.76%196.44M
Operating income
15.02%565.61M
103.15%336.44M
27.51%491.76M
-22.69%165.61M
-20.78%385.66M
-13.45%214.21M
19.51%486.85M
26.00%247.5M
-11.83%407.39M
-27.76%196.44M
Cost of sales
0.24%-266.1M
-83.19%-157.32M
-52.83%-266.74M
10.53%-85.88M
20.95%-174.53M
16.30%-95.98M
-13.28%-220.79M
-27.96%-114.67M
7.52%-194.9M
27.17%-89.62M
Operating expenses
0.24%-266.1M
-83.19%-157.32M
-52.83%-266.74M
10.53%-85.88M
20.95%-174.53M
16.30%-95.98M
-13.28%-220.79M
-27.96%-114.67M
7.52%-194.9M
27.17%-89.62M
Gross profit
33.10%299.51M
124.65%179.12M
6.58%225.02M
-32.56%79.73M
-20.65%211.13M
-10.99%118.23M
25.22%266.07M
24.35%132.83M
-15.45%212.49M
-28.24%106.82M
Selling expenses
-17.54%-139.54M
-77.36%-79.09M
-30.54%-118.72M
12.41%-44.59M
15.33%-90.95M
9.76%-50.91M
4.79%-107.41M
0.83%-56.42M
-25.92%-112.81M
-1.49%-56.89M
Administrative expenses
-36.81%-74.9M
-114.25%-59.78M
16.08%-54.75M
11.50%-27.9M
17.29%-65.24M
33.98%-31.53M
-34.30%-78.87M
-84.29%-47.76M
-19.12%-58.73M
9.18%-25.92M
Research and development expenses
-329.61%-65.2M
----
---15.18M
----
----
----
----
----
----
----
Impairment and provision
----
----
----
----
----
----
---22.64M
----
----
----
-Goodwill impairment
----
----
----
----
----
----
---22.64M
----
----
----
Special items of operating profit
-98.02%146K
-2,431.58%-1.44M
362.13%7.38M
-100.52%-57K
-159.46%-2.82M
119.95%11.06M
-81.21%4.73M
-40.77%5.03M
6.57%25.19M
-19.70%8.49M
Operating profit
-54.26%20.02M
440.55%38.8M
-16.07%43.76M
-84.68%7.18M
-15.75%52.14M
39.10%46.85M
-6.45%61.88M
3.62%33.68M
-51.39%66.15M
-56.57%32.5M
Financing income
-78.50%424K
-21.09%752K
-22.91%1.97M
-21.37%953K
79.01%2.56M
51.69%1.21M
-60.99%1.43M
-9.62%799K
9.47%3.66M
12.61%884K
Financing cost
47.64%-9.27M
72.50%-2.99M
-83.29%-17.7M
-53.86%-10.88M
-5.42%-9.66M
-46.37%-7.07M
13.04%-9.16M
16.87%-4.83M
32.48%-10.53M
37.00%-5.81M
Share of profits of associates
1.05%-9.11M
72.27%-859K
32.52%-9.2M
-62.20%-3.1M
---13.64M
---1.91M
----
----
----
----
Share of profit from joint venture company
5.33%-11.19M
-775.85%-12.81M
-201.26%-11.82M
-112.47%-1.46M
-51.88%11.67M
-4.17%11.72M
434.77%24.25M
--12.23M
--4.54M
----
Special items of earning before tax
46.51%-20.33M
----
-97.13%-38.01M
----
---19.28M
----
----
----
----
----
Earning before tax
4.98%-29.45M
413.09%22.9M
-230.27%-30.99M
-114.40%-7.31M
-69.66%23.79M
21.30%50.8M
22.86%78.41M
51.87%41.88M
-48.46%63.81M
-58.47%27.57M
Tax
-87.03%-6.85M
-2,832.63%-6.45M
49.00%-3.66M
103.38%236K
54.39%-7.18M
17.27%-6.99M
-36.19%-15.74M
-119.86%-8.45M
47.25%-11.56M
70.23%-3.84M
After-tax profit from continuing operations
-4.74%-36.3M
332.40%16.45M
-308.60%-34.65M
-116.15%-7.08M
-73.49%16.61M
31.05%43.81M
19.92%62.67M
40.86%33.43M
-48.72%52.26M
-55.63%23.73M
Earning after tax
-4.74%-36.3M
332.40%16.45M
-308.60%-34.65M
-116.15%-7.08M
-73.49%16.61M
31.05%43.81M
19.92%62.67M
40.86%33.43M
-48.72%52.26M
-55.63%23.73M
Minority profit
63.27%-18K
77.50%-9K
-53.13%-49K
63.64%-40K
99.57%-32K
92.69%-110K
-535.15%-7.46M
-2,053.25%-1.5M
-4,451.85%-1.18M
955.56%77K
Profit attributable to shareholders
-4.83%-36.28M
333.85%16.46M
-307.90%-34.61M
-116.02%-7.04M
-76.27%16.65M
25.72%43.92M
31.25%70.13M
47.68%34.93M
-47.55%53.43M
-55.78%23.66M
Basic earnings per share
0.00%-0.05
300.00%0.02
-350.00%-0.05
-116.67%-0.01
-77.78%0.02
50.00%0.06
28.57%0.09
33.33%0.04
-53.33%0.07
-66.67%0.03
Diluted earnings per share
0.00%-0.05
300.00%0.02
-350.00%-0.05
-116.67%-0.01
-77.78%0.02
50.00%0.06
28.57%0.09
33.33%0.04
-53.33%0.07
-66.67%0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 15.02%565.61M103.15%336.44M27.51%491.76M-22.69%165.61M-20.78%385.66M-13.45%214.21M19.51%486.85M26.00%247.5M-11.83%407.39M-27.76%196.44M
Operating income 15.02%565.61M103.15%336.44M27.51%491.76M-22.69%165.61M-20.78%385.66M-13.45%214.21M19.51%486.85M26.00%247.5M-11.83%407.39M-27.76%196.44M
Cost of sales 0.24%-266.1M-83.19%-157.32M-52.83%-266.74M10.53%-85.88M20.95%-174.53M16.30%-95.98M-13.28%-220.79M-27.96%-114.67M7.52%-194.9M27.17%-89.62M
Operating expenses 0.24%-266.1M-83.19%-157.32M-52.83%-266.74M10.53%-85.88M20.95%-174.53M16.30%-95.98M-13.28%-220.79M-27.96%-114.67M7.52%-194.9M27.17%-89.62M
Gross profit 33.10%299.51M124.65%179.12M6.58%225.02M-32.56%79.73M-20.65%211.13M-10.99%118.23M25.22%266.07M24.35%132.83M-15.45%212.49M-28.24%106.82M
Selling expenses -17.54%-139.54M-77.36%-79.09M-30.54%-118.72M12.41%-44.59M15.33%-90.95M9.76%-50.91M4.79%-107.41M0.83%-56.42M-25.92%-112.81M-1.49%-56.89M
Administrative expenses -36.81%-74.9M-114.25%-59.78M16.08%-54.75M11.50%-27.9M17.29%-65.24M33.98%-31.53M-34.30%-78.87M-84.29%-47.76M-19.12%-58.73M9.18%-25.92M
Research and development expenses -329.61%-65.2M-------15.18M----------------------------
Impairment and provision ---------------------------22.64M------------
-Goodwill impairment ---------------------------22.64M------------
Special items of operating profit -98.02%146K-2,431.58%-1.44M362.13%7.38M-100.52%-57K-159.46%-2.82M119.95%11.06M-81.21%4.73M-40.77%5.03M6.57%25.19M-19.70%8.49M
Operating profit -54.26%20.02M440.55%38.8M-16.07%43.76M-84.68%7.18M-15.75%52.14M39.10%46.85M-6.45%61.88M3.62%33.68M-51.39%66.15M-56.57%32.5M
Financing income -78.50%424K-21.09%752K-22.91%1.97M-21.37%953K79.01%2.56M51.69%1.21M-60.99%1.43M-9.62%799K9.47%3.66M12.61%884K
Financing cost 47.64%-9.27M72.50%-2.99M-83.29%-17.7M-53.86%-10.88M-5.42%-9.66M-46.37%-7.07M13.04%-9.16M16.87%-4.83M32.48%-10.53M37.00%-5.81M
Share of profits of associates 1.05%-9.11M72.27%-859K32.52%-9.2M-62.20%-3.1M---13.64M---1.91M----------------
Share of profit from joint venture company 5.33%-11.19M-775.85%-12.81M-201.26%-11.82M-112.47%-1.46M-51.88%11.67M-4.17%11.72M434.77%24.25M--12.23M--4.54M----
Special items of earning before tax 46.51%-20.33M-----97.13%-38.01M-------19.28M--------------------
Earning before tax 4.98%-29.45M413.09%22.9M-230.27%-30.99M-114.40%-7.31M-69.66%23.79M21.30%50.8M22.86%78.41M51.87%41.88M-48.46%63.81M-58.47%27.57M
Tax -87.03%-6.85M-2,832.63%-6.45M49.00%-3.66M103.38%236K54.39%-7.18M17.27%-6.99M-36.19%-15.74M-119.86%-8.45M47.25%-11.56M70.23%-3.84M
After-tax profit from continuing operations -4.74%-36.3M332.40%16.45M-308.60%-34.65M-116.15%-7.08M-73.49%16.61M31.05%43.81M19.92%62.67M40.86%33.43M-48.72%52.26M-55.63%23.73M
Earning after tax -4.74%-36.3M332.40%16.45M-308.60%-34.65M-116.15%-7.08M-73.49%16.61M31.05%43.81M19.92%62.67M40.86%33.43M-48.72%52.26M-55.63%23.73M
Minority profit 63.27%-18K77.50%-9K-53.13%-49K63.64%-40K99.57%-32K92.69%-110K-535.15%-7.46M-2,053.25%-1.5M-4,451.85%-1.18M955.56%77K
Profit attributable to shareholders -4.83%-36.28M333.85%16.46M-307.90%-34.61M-116.02%-7.04M-76.27%16.65M25.72%43.92M31.25%70.13M47.68%34.93M-47.55%53.43M-55.78%23.66M
Basic earnings per share 0.00%-0.05300.00%0.02-350.00%-0.05-116.67%-0.01-77.78%0.0250.00%0.0628.57%0.0933.33%0.04-53.33%0.07-66.67%0.03
Diluted earnings per share 0.00%-0.05300.00%0.02-350.00%-0.05-116.67%-0.01-77.78%0.0250.00%0.0628.57%0.0933.33%0.04-53.33%0.07-66.67%0.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg